Tech Company Financing Transactions
Biostate AI Funding Round
On 5/21/2025, Biostate AI secured $12 million in Series A funding from Accel Partners, Catapult Ventures and Gaingels.
Transaction Overview
Company Name
Announced On
5/21/2025
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
Accel Partners (Lead Investor)
private investors (Dario Amodei)
private investors (Emily Leproust)
private investors (Mike Schnall-Levin)
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
7505 Fannin St. 610
Houston, TX 77054
USA
Houston, TX 77054
USA
Phone
Website
Email Address
Overview
At Biostate.ai, we believe biology is inherently generative, today's state determines tomorrow's outcomes. In some sense this is similar to how ChatGPT enables a few words to generate future words. Our vision is to make biological systems and healthcare predictable by capturing and understanding these dynamic transitions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Zhang
Chief Operating Officer
Eva Miao
Chief Technical Officer
Ashwin Gopinath
Chief Technical Officer
Timothy Kassis
VP - R & D
Paul Rothemund
Browse more venture capital transactions:
Prev: 5/21/2025: Legora venture capital transaction
Next: 5/21/2025: Pay-i venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs